Adjusted organic sales grew 3% in Q2, with strong technology and solutions performance, especially in North America. Operating margin and EPS improved, and the 2030 strategy targets 10% annual EPS growth. Liquidity and leverage metrics strengthened.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.